News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
537,639 Results
Type
Article (34270)
Company Profile (138)
Press Release (503231)
Multimedia
Podcasts (48)
Webinars (11)
Section
Business (151012)
Career Advice (1065)
Deals (26827)
Drug Delivery (101)
Drug Development (62271)
Employer Resources (111)
FDA (13372)
Job Trends (12289)
News (257518)
Policy (25643)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2420)
Academic (2)
Accelerated approval (5)
Adcomms (14)
Allergies (77)
Alliances (38590)
ALS (75)
Alzheimer's disease (1211)
Antibody-drug conjugate (ADC) (83)
Approvals (13407)
Artificial intelligence (235)
Autoimmune disease (19)
Automation (10)
Bankruptcy (216)
Best Places to Work (10688)
BIOSECURE Act (13)
Biosimilars (94)
Biotechnology (84)
Bladder cancer (56)
Brain cancer (23)
Breast cancer (220)
Cancer (1733)
Cardiovascular disease (148)
Career advice (927)
Career pathing (19)
CAR-T (127)
Cell therapy (345)
Cervical cancer (16)
Clinical research (51357)
Collaboration (707)
Compensation (115)
Complete response letters (13)
COVID-19 (2513)
CRISPR (35)
C-suite (185)
Cystic fibrosis (85)
Data (1808)
Decentralized trials (2)
Denatured (21)
Depression (35)
Diabetes (224)
Diagnostics (5838)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (34)
Drug discovery (100)
Drug pricing (106)
Drug shortages (14)
Duchenne muscular dystrophy (72)
Earnings (63221)
Editorial (27)
Employer branding (14)
Employer resources (100)
Events (93335)
Executive appointments (604)
FDA (14497)
Featured Employer (37)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (653)
Gene editing (86)
Generative AI (22)
Gene therapy (244)
GLP-1 (573)
Government (4554)
Grass and pollen (4)
Guidances (49)
Healthcare (17980)
Huntington's disease (16)
IgA nephropathy (20)
Immunology and inflammation (86)
Indications (24)
Infectious disease (2656)
Inflammatory bowel disease (111)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (68)
Interviews (164)
IPO (13575)
IRA (42)
Job creations (2067)
Job search strategy (802)
Kidney cancer (7)
Labor market (16)
Layoffs (336)
Leadership (10)
Legal (4877)
Liver cancer (61)
Lung cancer (240)
Lymphoma (114)
Machine learning (5)
Management (37)
Manufacturing (224)
MASH (51)
Medical device (11991)
Medtech (11994)
Mergers & acquisitions (13751)
Metabolic disorders (572)
Multiple sclerosis (67)
NASH (13)
Neurodegenerative disease (76)
Neuropsychiatric disorders (16)
Neuroscience (1642)
NextGen: Class of 2025 (5935)
Non-profit (4475)
Northern California (2149)
Now hiring (8)
Obesity (313)
Opinion (177)
Ovarian cancer (55)
Pain (66)
Pancreatic cancer (75)
Parkinson's disease (115)
Partnered (18)
Patents (162)
Patient recruitment (93)
Peanut (43)
People (40946)
Pharmaceutical (40)
Pharmacy benefit managers (19)
Phase I (16742)
Phase II (22106)
Phase III (16809)
Pipeline (1022)
Policy (132)
Postmarket research (1922)
Preclinical (5539)
Press Release (56)
Prostate cancer (88)
Psychedelics (25)
Radiopharmaceuticals (209)
Rare diseases (333)
Real estate (3947)
Recruiting (44)
Regulatory (18014)
Reports (29)
Research institute (2222)
Resumes & cover letters (138)
Rett syndrome (4)
RNA editing (3)
RSV (40)
Schizophrenia (57)
Series A (108)
Series B (71)
Service/supplier (5)
Sickle cell disease (57)
Southern California (1808)
Special edition (9)
Spinal muscular atrophy (131)
Sponsored (24)
Startups (2809)
Stomach cancer (9)
Supply chain (61)
Tariffs (18)
The Weekly (25)
United States (19139)
Vaccines (649)
Venture capitalists (29)
Weight loss (193)
Women's health (34)
Worklife (8)
Date
Today (69)
Last 7 days (374)
Last 30 days (1930)
Last 365 days (28633)
2025 (8312)
2024 (30384)
2023 (34638)
2022 (44817)
2021 (48857)
2020 (47989)
2019 (41521)
2018 (31259)
2017 (25404)
2016 (25234)
2015 (29707)
2014 (22230)
2013 (17334)
2012 (18384)
2011 (19051)
2010 (16746)
Location
Africa (664)
Alabama (44)
Alaska (7)
Arizona (139)
Arkansas (13)
Asia (29817)
Australia (5270)
California (4868)
Canada (1629)
China (397)
Colorado (234)
Connecticut (244)
Delaware (115)
Europe (67626)
Florida (758)
Georgia (190)
Hawaii (1)
Idaho (47)
Illinois (454)
India (23)
Indiana (295)
Iowa (6)
Japan (137)
Kansas (100)
Kentucky (20)
Louisiana (11)
Maine (70)
Maryland (786)
Massachusetts (3608)
Michigan (181)
Minnesota (337)
Mississippi (2)
Missouri (84)
Montana (28)
Nebraska (21)
Nevada (57)
New Hampshire (67)
New Jersey (1517)
New Mexico (26)
New York (1479)
North Carolina (861)
North Dakota (5)
Northern California (2149)
Ohio (161)
Oklahoma (12)
Oregon (27)
Pennsylvania (1125)
Puerto Rico (11)
Rhode Island (24)
South America (893)
South Carolina (17)
South Dakota (1)
Southern California (1808)
Tennessee (97)
Texas (708)
Utah (168)
Virginia (121)
Washington D.C. (56)
Washington State (483)
West Virginia (3)
Wisconsin (50)
537,639 Results for "clinton health access initiative".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NervGen Initiates Expanded Access Policy
March 31, 2025
·
8 min read
Press Releases
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™
March 28, 2025
·
5 min read
Press Releases
ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks
March 12, 2025
·
3 min read
Press Releases
Merz Therapeutics and World Stroke Organization Launch ‘Access to Health’ Initiative to Improve Stroke Care in Africa
October 24, 2024
·
4 min read
Press Releases
Ivím Health Files Amicus Brief Fighting for Patient Access to GLP-1 Medications as Critical March Deadline Looms
February 4, 2025
·
2 min read
Press Releases
MedaSystems Secures Additional Seed Financing to Advance Its AI-Driven Workflow Platform for Expanded Access and Investigator-Initiated Studies
March 5, 2025
·
2 min read
Job Trends
Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries
Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries.
November 13, 2023
·
5 min read
Government
WHO Withdrawal, CGT Access, IRA: Trump’s Initial Policies Raise Questions for Biopharma
At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, President Trump issued multiple executive orders that concern the industry.
January 22, 2025
·
5 min read
·
Annalee Armstrong
Biotech Beach
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
CG Oncology, Inc. announced that it has initiated an Expanded Access Program for cretostimogene grenadenorepvec in the U.S. for patients with Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette-Guerin and meet certain program eligibility criteria.
June 18, 2024
·
5 min read
Business
Remission Medical Partners with Sentara Health to Expand Access to Rheumatology Care
Remission Medical announced a partnership with Sentara Health to increase access to Rheumatology care for adult patients.
March 20, 2024
·
2 min read
1 of 53,764
Next
